Plain-English translation of NCT07045142 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research is testing whether the medication can prevent blood sugar problems in people with schizophrenia who are taking a cholesterol medication called . Cholesterol medications are important for heart health in people with schizophrenia, but they can sometimes cause blood sugar to rise. This study wants to see if adding this medication can protect against that side effect.
People with schizophrenia are at higher risk for heart disease and often need cholesterol medication to stay healthy. However, this medication can increase the chance of developing diabetes—a complication that hasn't been well studied in this group. Researchers want to find out if this treatment can safely prevent blood sugar problems while people take their cholesterol medication.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either the medication or a placebo (a pill with no active ingredient) while you continue your regular cholesterol medication. You will need to have blood tests done at the beginning and several times during the study to measure your blood sugar and cholesterol levels. The study will track how your body responds to the cholesterol medication and whether the added medication helps prevent blood sugar problems.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
China